ASP Isotopes (NASDAQ:ASPI) Announces Quarterly Earnings Results

ASP Isotopes (NASDAQ:ASPI – Get Free Report) posted its earnings results on Monday. The company reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.15) by ($0.13), FiscalAI reports. ASP Isotopes had a negative return on equity of 64.99% and a negative net margin of 427.98%. The firm had revenue of $5.12 million during the quarter, compared to analysts’ expectations of $5.68 million.

ASP Isotopes Trading Down 11.5%

ASPI traded down $0.20 on Monday, hitting $1.54. The company had a trading volume of 4,475,844 shares, compared to its average volume of 4,713,274. The company has a quick ratio of 3.85, a current ratio of 3.87 and a debt-to-equity ratio of 0.76. ASP Isotopes has a 12-month low of $1.53 and a 12-month high of $8.60. The company has a market cap of $236.10 million, a PE ratio of -1.17 and a beta of 3.77. The business’s fifty day simple moving average is $2.57 and its 200 day simple moving average is $4.59.

Insider Activity

In other news, CEO Paul Mann sold 83,759 shares of the firm’s stock in a transaction dated Friday, September 4th. The shares were sold at an average price of $4.10, for a total value of $343,411.90. Following the completion of the sale, the chief executive officer owned 9,328,570 shares in the company, valued at approximately $38,247,137. This trade represents a 0.89% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Heather Kiessling sold 21,830 shares of ASP Isotopes stock in a transaction dated Friday, October 16th. The stock was sold at an average price of $2.19, for a total transaction of $47,807.70. Following the transaction, the chief financial officer directly owned 1,504,422 shares of the company’s stock, valued at approximately $3,294,684.18. This represents a 1.43% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders sold 245,285 shares of company stock worth $899,887. Insiders own 14.40% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have issued reports on the company. Wall Street Zen raised ASP Isotopes from a “strong sell” rating to a “sell” rating in a research note on Saturday, August 22nd. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ASP Isotopes in a report on Monday, September 21st. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $12.00.

Read Our Latest Analysis on ASPI

ASP Isotopes Company Profile

(Get Free Report)

ASP Isotopes Inc. is an advanced materials company focused on producing and commercializing enriched isotopes. Its proprietary Aerodynamic Separation Process is designed to separate isotopes and support production across a range of applications. The company’s targeted products include isotopes used in medical imaging and pharmaceuticals, semiconductor manufacturing, quantum technologies and nuclear energy. Examples include molybdenum-100, silicon-28 and ytterbium-176. ASP Isotopes is headquartered in the United States and has pursued isotope-enrichment operations in South Africa.

Read More

Earnings History for ASP Isotopes (NASDAQ:ASPI)

Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.